Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Cherry, Jonathan J ^a,b   Rietz, Anne ^b   Malinkevich, Anna ^a   Liu, Yuqi ^c   Xie, Meng ^a,b   Bartolowits, Matthew ^d   Davisson, V Jo ^d   Baleja, James D ^c   Androphy, Elliot J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG DISCOVERY; FEMALE; FLAVONOIDS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUTEOLIN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS;

EID: 84893472674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084506     Document Type: Article

References (59)

1. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527. doi:10.1056/NEJMoa021641. PubMed: 12571259. (Pubitemid 36159887)
2. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698. doi:10.1093/jnci/92.9.690. PubMed: 10793105.
3. McKaig RG, Baric RS, Olshan AF (1998) Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250-265. doi:10.1002/(SICI)1097-0347(199805)20:3. PubMed: 9570632. (Pubitemid 28169738)
4. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720. doi:10.1093/jnci/92.9. 709. PubMed: 10793107. (Pubitemid 30365531)
5. Howie HL, Katzenellenbogen RA, Galloway DA (2009) Papillomavirus E6 proteins. Virology 384: 324-334. doi:10.1016/j.virol.2008.11.017. PubMed: 19081593.
6. Tungteakkhun SS, Duerksen-Hughes PJ (2008) Cellular binding partners of the human papillomavirus E6 protein. Arch Virol 153: 397-408. PubMed: 18172569.
7. Kho EY, Wang HK, Banerjee NS, Broker TR, Chow LT (2013) HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc Natl Acad Sci U S A 110: 7542-7549. doi:10.1073/pnas.1304855110. PubMed: 23572574.
8. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505. doi:10.1016/0092-8674(93)90384-3. PubMed: 8221889. (Pubitemid 23335075)
9. Scheffner M, Huibregtse JM, Howley PM (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci U S A 91: 8797-8801. doi:10.1073/pnas.91.19.8797. PubMed: 8090726.
10. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncorprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129-4135. PubMed: 1661671. (Pubitemid 21905444)
11. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53. doi:10.1126/science.1905840. PubMed: 1905840. (Pubitemid 21917115)
12. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310. doi:10.1038/35042675. PubMed: 11099028.
13. Park RB, Androphy EJ (2002) Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol 76: 11359-11364. doi:10.1128/JVI.76.22.11359-11364.2002. PubMed: 12388696. (Pubitemid 35231291)
14. Thomas M, Pim D, Banks L (1999) The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690-7700. doi:10.1038/sj.onc. 1202953. PubMed: 10618709. (Pubitemid 30052696)
15. Chen JJ, Hong YH, Rustamzadeh E, Baleja JD, Androphy EJ (1998) Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem 273: 13537-13544. doi:10.1074/jbc.273.22.13537. PubMed: 9593689. (Pubitemid 28268395)
16. Be X, Hong Y, Wei J, Androphy EJ, Chen JJ et al. (2001) Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry 40: 1293-1299. doi:10.1021/bi0019592. PubMed: 11170455. (Pubitemid 32142890)
17. Liu Y, Liu Z, Androphy E, Chen J, Baleja JD (2004) Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus. Biochemistry 43: 7421-7431. doi:10.1021/bi049552a. PubMed: 15182185. (Pubitemid 38745759)
18. Baleja JD, Cherry JJ, Liu Z, Gao H, Nicklaus MC et al. (2006) Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res 72: 49-59. doi:10.1016/j.antiviral.2006.03.014. PubMed: 16690141. (Pubitemid 44291470)
19. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82. doi:10.1038/380079a0. PubMed: 8598912. (Pubitemid 26076241)
20. Stöppler H, Hartmann DP, Sherman L, Schlegel R (1997) The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem 272: 13332-13337. doi:10.1074/jbc.272.20.13332. PubMed: 9148955. (Pubitemid 27216765)
21. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T et al. (1997) Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94: 11612-11616. doi:10.1073/pnas.94.21.11612. PubMed: 9326658. (Pubitemid 27451047)
22. Kuballa P, Matentzoglu K, Scheffner M (2007) The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem 282: 65-71. PubMed: 17085449. (Pubitemid 47076595)
23. Grm HS, Banks L (2004) Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J Gen Virol 85: 2815-2819.
24. Foster SA, Demers GW, Etscheid BG, Galloway DA (1994) The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68: 5698-5705. PubMed: 8057451.
25. Dalal S, Gao QS, Androphy EJ, Band V (1996) Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol 70: 683-688. PubMed: 8551603. (Pubitemid 26028982)
26. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910. PubMed: 2555178. (Pubitemid 20016074)
27. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421. PubMed: 2476573. (Pubitemid 19229441)
28. Hudson JB, Bedell MA, McCance DJ, Laiminis LA (1990) Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64: 519-526. PubMed: 2153221. (Pubitemid 20032661)
29. Liu Y, Chen JJ, Gao QS, Dalal S, Hong YH et al. (1999) Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 73: 7297-7307. PubMed: 10438818. (Pubitemid 29383212)
30. Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J (2007) Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol 39: 2006-2011. doi:10.1016/j.biocel.2007.07.004. PubMed: 17768080. (Pubitemid 47369247)
31. Wise-Draper TM, Wells SI (2008) Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 13: 1003-1017. doi:10.2741/2739. PubMed: 17981607. (Pubitemid 351594744)
32. Song S, Liem A, Miller JA, Lambert PF (2000) Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267: 141-150. doi:10.1006/viro.1999.0106. PubMed: 10662610. (Pubitemid 30123597)
33. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD et al. (2000) Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 19: 5762-5771. doi:10.1093/emboj/19.21.5762. PubMed: 11060027.
34. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D et al. (2000) Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci U S A 97: 10978-10983. doi:10.1073/pnas.97.20.10978. PubMed: 11005870.
35. Fradet-Turcotte A, Archambault J (2007) Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther 12: 431-451. PubMed: 17668552. (Pubitemid 47041143)
36. Hall WS, Goto-Mandeville R, Shih HA, Shank PR, Braun L (1997) Molecular analysis of episomal human papillomavirus type 16 DNA in a cervical carcinoma cell line. Virus Res 51: 183-195. doi:10.1016/S0168-1702(97)00095-6. PubMed: 9498616. (Pubitemid 27483592)
37. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A et al. (1995) Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10: 927-936. PubMed: 7898934.
38. Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG et al. (2013) Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 339: 694-698. doi:10.1126/science.1229934. PubMed: 23393263.
39. Sekaric P, Cherry JJ, Androphy EJ (2008) Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT. J Virol 82: 71-76. doi:10.1128/JVI.01776-07. PubMed: 17942561. (Pubitemid 350309124)
40. Yamabhai M, Kay BK (2001) Mapping protein-protein interactions with alkaline phosphatase fusion proteins. Methods Enzymol 332: 88-102. doi:10.1016/S0076-6879(01)32194-8. PubMed: 11305120. (Pubitemid 32275374)
41. Zanier K, Charbonnier S, Baltzinger M, Nominé Y, Altschuh D et al. (2005) Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J Mol Biol 349: 401-412. doi:10.1016/j.jmb.2005.03.071. PubMed: 15890204. (Pubitemid 40693758)
42. Das K, Bohl J, Vande Pol SB (2000) Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP. J Virol 74: 812-816. doi:10.1128/JVI.74.2.812-816.2000. PubMed: 10623743. (Pubitemid 30036217)
43. Liu Y, Cherry JJ, Dineen JV, Androphy EJ, Baleja JD (2009) Determinants of stability for the E6 protein of papillomavirus type 16. J Mol Biol 386: 1123-1137. doi:10.1016/j.jmb.2009.01.018. PubMed: 19244625.
44. Chahar MK, Sharma N, Dobhal MP, Joshi YC (2011) Flavonoids: A versatile source of anticancer drugs. Pharmacogn Rev 5: 1-12. doi:10.4103/0973-7847.79093. PubMed: 22096313.
45. Lee HG, Yu KA, Oh WK, Baeg TW, Oh HC et al. (2005) Inhibitory effect of jaceosidin isolated from Artemisiaargyi on the function of E6 and E7 oncoproteins of HPV 16. J Ethnopharmacol 98: 339-343. doi:10.1016/j.jep.2005.01. 054. PubMed: 15814270.
46. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23: 519-534. doi:10.1002/med.10033. PubMed: 12710022. (Pubitemid 36706514)
47. Zanier K, ould M'hamed ould Sidi A, Boulade-Ladame C, Rybin V, Chappelle A et al. (2012) Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 20: 604-617.
48. Kranz JK, Schalk-Hihi C (2011) Protein thermal shifts to identify low molecular weight fragments. Methods Enzymol 493: 277-298. PubMed: 21371595.
49. Schrodinger L (2011) Maestro. New York, NY.
50. Schrodinger L (2011) LigPrep. New York, NY.
51. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47: 1739-1749. doi:10.1021/jm0306430. PubMed: 15027865. (Pubitemid 38380917)
52. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47: 1750-1759. doi:10.1021/jm030644s. PubMed: 15027866. (Pubitemid 38380918)
53. Nominé Y, Masson M, Charbonnier S, Zanier K, Ristriani T et al. (2006) Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 21: 665-678. doi:10.1016/j.molcel.2006.01.024. PubMed: 16507364. (Pubitemid 43290733)
54. Sidi AO, Babah KO, Brimer N, Nominé Y, Romier C et al. (2011) Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6. Protein Expr Purif 80: 8-16. doi:10.1016/j.pep.2011.06.013. PubMed: 21777678.
55. Yuan CH, Filippova M, Tungteakkhun SS, Duerksen-Hughes PJ, Krstenansky JL (2012) Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg Med Chem Lett 22: 2125-2129. doi:10.1016/j.bmcl.2011.12.145. PubMed: 22300659.
56. Matta CF, Arabi AA, Weaver DF (2010) The bioisosteric similarity of the tetrazole and carboxylate anions: clues from the topologies of the electrostatic potential and of the electron density. Eur J Med Chem 45: 1868-1872. doi:10.1016/j.ejmech.2010.01.025. PubMed: 20133027.
57. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771. doi:10.1083/jcb.106.3.761. PubMed: 2450098. (Pubitemid 18089976)
58. Zanier K, Nominé Y, Charbonnier S, Ruhlmann C, Schultz P et al. (2007) Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species. Protein Expr Purif 51: 59-70. doi:10.1016/j.pep.2006.07.029. PubMed: 17055740. (Pubitemid 44822662)
59. Lewis DA, Travers JB, Somani AK, Spandau DF (2010) The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene 29: 1475-1485. doi:10.1038/onc.2009.440. PubMed: 19966862.